Health & Medicine

1. 3 minutes of sprinting does something 90 minutes of exercise does not

   A few minutes of sprinting may reshape the bloodstream far more dramatically than a much longer moderate workout. Six 30-second sprints altered nearly a quarter of the blood proteins measured and more than 200 metabolites, while 90 minutes of moderate cycling produced far smaller immediate changes. Many of the proteins affected by sprinting were also associated with lower risks of obesity, type 2 diabetes, and other metabolic diseases.

2. This weight-loss hormone may protect the liver even without weight loss

   A hormone already known for curbing appetite and supporting weight loss may have a surprising second job: protecting the liver from inflammation and scarring. Researchers at McMaster University found that GDF15 activates a previously unknown brain-to-liver pathway that triggers the release of glucocorticoids, helping calm immune activity in the liver.

3. AI may know how you’ll respond to a vaccine before you get it

   AI may be able to predict how strongly someone will respond to a vaccine before they receive it. By analyzing antibody patterns in more than 4,000 people, researchers found signs of “immune readiness” that helped distinguish strong responders from weak ones. Surprisingly, even some healthy people responded poorly, while some immunosuppressed people mounted strong responses.

4. A simple at-home test could cut colorectal cancer death risk by 43%

   People who participated in colorectal cancer screening had a 43% lower risk of dying from the disease, according to long-term data from more than 376,000 people in Sweden. The findings suggest that completing a simple at-home screening test could make a major difference in survival.

5. Schizophrenia’s lost brain connections follow a surprising pattern

   Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.

6. Scientists discover how gut bacteria “train” the intestine to fight inflammation

   A compound made when gut bacteria break down dietary fiber may do more than briefly calm inflammation—it could leave a lasting protective “memory” in the gut. Northwestern Medicine researchers found that butyrate can reprogram intestinal lining cells so they continue encouraging anti-inflammatory immune responses even after the compound is gone. In mice, this effect boosted production of the immune-calming molecule IL-10 and reduced the severity of colitis-like disease.

7. Ozempic does something unexpected to the brain’s hunger neurons

   Ozempic may work in the brain in almost the opposite way scientists expected, activating hunger-linked neurons that appear essential for sustaining fat loss. The surprising discovery in mice could reveal new targets for developing even more effective obesity drugs.

8. Knee osteoarthritis isn’t inevitable — here’s what you can do

   Knee osteoarthritis can seriously affect mobility and quality of life, but its progression isn’t completely out of your control. Exercise, stronger leg muscles, a healthier diet, and even modest weight loss can dramatically reduce stress on the knees and help keep pain in check.

9. AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND

   Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.

10. More than 1,000 genetic switches reveal why female immunity is different

    More than 1,000 genetic switches behave differently in male and female immune cells, helping explain why women are much more vulnerable to autoimmune diseases such as lupus. Female immune systems appear genetically tuned for stronger inflammatory responses—a powerful defense against infection that may also make dangerous immune misfires more likely.

11. Coffee drinkers have less fat, more muscle, and surprising hormone differences

    Coffee drinkers may be getting more than an energy boost. A Finnish study found that people who drank more coffee tended to have less total and abdominal fat, more muscle, and healthier metabolic markers despite having similar BMIs. Higher coffee intake was also linked to lower levels of certain amino acids associated with insulin resistance and type 2 diabetes risk.

12. A mother’s age can shape her offspring without changing their DNA

    Scientists have found evidence that the effects of a mother’s age on her offspring may be driven by reversible changes in gene activity rather than permanent DNA damage. The discovery raises the fascinating possibility that biological information from mothers, grandmothers, and even great-grandmothers can shape the health of future generations.

13. Tiny robots powered by light can hunt down and collect bacteria

    Researchers have built microscopic, light-driven robots that can rapidly navigate through liquid, collect bacteria, and deposit them in chosen locations. These tiny “cleaners” could open new possibilities for manipulating cells and microbes with remarkable precision.

14. The bacteria that make cheese taste so good may also benefit your gut

    Scientists studying three artisan British cheeses found that the microbes responsible for their distinctive flavors may also offer surprising benefits for gut health. As the cheeses matured, helpful bacteria transformed their aromas and textures while potentially producing compounds linked to reduced inflammation, cholesterol regulation, and appetite control.

15. Widely prescribed blood pressure drugs linked to 33% higher kidney risk in type 2 diabetes

    A widely prescribed blood pressure drug was associated with a 33% higher risk of serious kidney problems in people with type 2 diabetes, even when they were already taking kidney-protective medications. The surprising finding is prompting researchers to question whether DCCBs are always the safest second-line choice for diabetic kidney disease.